Femasys (FEMY) Depreciation & Amortization (CF) (2020 - 2026)
Femasys (FEMY) posted Depreciation & Amortization (CF) of $65578.0 for Q1 2026, down 4.25% on a QoQ basis from $68488.0 in Q4 2025, and down 15.58% year-over-year from $77682.0 in Q1 2025.
Femasys (FEMY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Femasys' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $65578.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 15.58% year-over-year to $65578.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $283755.0 (changed 0.39% YoY) and the FY2025 annual result came in at $295859.0, up 6.74% from the prior year.
- Depreciation & Amortization (CF) was $65578.0 for Q1 2026 at Femasys, down from $68488.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $136769.0 in Q1 2022 and bottomed at $63045.0 in Q2 2024.
- A 5-year average of $97543.3 and a median of $77682.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) tumbled 52.38% — and 2025, when it rose 23.19%.
- Femasys' Depreciation & Amortization (CF) stood at $132288.0 in 2022, then sank by 30.9% to $91410.0 in 2023, then decreased by 18.82% to $74207.0 in 2024, then retreated by 7.71% to $68488.0 in 2025, then dropped by 4.25% to $65578.0 in 2026.
- Business Quant data shows FEMY's Depreciation & Amortization (CF) at $65578.0 in Q1 2026, $68488.0 in Q4 2025, and $72022.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | 65,578.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,578.00 |
| Mar 31, 2026 | 65,578.00 |
| Dec 31, 2025 | 68,488.00 |
| Dec 31, 2025 | 68,488.00 |
| Sep 30, 2025 | 72,022.00 |
| Sep 30, 2025 | 72,022.00 |
| Jun 30, 2025 | 77,667.00 |
| Jun 30, 2025 | 77,667.00 |
| Mar 31, 2025 | 77,682.00 |
| Mar 31, 2025 | 77,682.00 |
| Dec 31, 2024 | 74,207.00 |
| Dec 31, 2024 | 74,207.00 |
| Sep 30, 2024 | 69,943.00 |
| Sep 30, 2024 | 69,943.00 |
| Jun 30, 2024 | 63,045.00 |
| Jun 30, 2024 | 63,045.00 |
| Mar 31, 2024 | 69,983.00 |
| Mar 31, 2024 | 69,983.00 |
| Dec 31, 2023 | 91,410.00 |
| Dec 31, 2023 | 91,410.00 |